Subsequent Events	12 Months Ended
Dec. 31, 2025
Subsequent Events [Abstract]
Subsequent Events [Text Block]	11. Subsequent Events On January 29, 2026, the Compensation Committee of the Board of Directors approved the grant of 150,000 stock options to a consultant and 50,000 stock options to an employee. The options were granted with an exercise price of $0.77 per share, expire five years from the date of grant, and vest immediately upon issuance. On January 6, 2026, a consultant exercised stock options to purchase an aggregate of 250,000 shares of the Company's common stock. The options exercised consisted of 100,000 shares at an exercise price of $0.10 per share and 150,000 shares at an exercise price of $0.20 per share. The Company received aggregate gross proceeds of $40,000 in connection with the exercise and issued 250,000 shares of common stock in accordance with the terms of the applicable stock option agreements.

Subsequent Events

12 Months Ended

Dec. 31, 2025

11. Subsequent Events

On January 29, 2026, the Compensation Committee of the Board of Directors approved the grant of 150,000 stock options to a consultant and 50,000 stock options to an employee. The options were granted with an exercise price of $0.77 per share, expire five years from the date of grant, and vest immediately upon issuance.

On January 6, 2026, a consultant exercised stock options to purchase an aggregate of 250,000 shares of the Company's common stock. The options exercised consisted of 100,000 shares at an exercise price of $0.10 per share and 150,000 shares at an exercise price of $0.20 per share. The Company received aggregate gross proceeds of $40,000 in connection with the exercise and issued 250,000 shares of common stock in accordance with the terms of the applicable stock option agreements.